Overview

Study of MAR002 in Healthy Men

Status:
RECRUITING
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Phase:
PHASE1
Details
Lead Sponsor:
Marea Therapeutics